PBF Energy CEO Exercises Options, Sells $16.2M in Stock
PBF has more than doubled off its 52-week low of $21.46.
Summary
PBF Energy CEO Matthew Lucey exercised options and sold all 225,473 shares for $16.2 million, reducing his direct stake to 615,771 shares. The sale follows a massive Q2 earnings beat and strong operational guidance.
Key Events · Ownership and Investor Activity · PBF
-
CEO Exercises and Sells Entire Option Tranche
Matthew Lucey exercised 225,473 options (strike $28.67–$32.71) and sold all resulting shares for $16.2 million at $71.62–$72.25, reducing direct holdings to 615,771 shares.
-
Discretionary Sale After Strong Earnings
The sale occurred two trading days after PBF reported Q2 net income of $915 million and guided Q3 refinery runs up to 92% of capacity, yet the CEO chose to liquidate the entire exercised position.
-
No 10b5-1 Plan Protection
The filing indicates the sale was not executed under a pre-arranged trading plan, suggesting a discretionary decision rather than a scheduled divestiture.
-
Insider Distribution Pattern Continues
Over the past 90 days, PBF insiders have sold $177.5 million in open-market transactions with zero purchases, indicating a persistent distribution trend among executives.
Analysis · PBF · Energy & Transportation
CEO Matthew Lucey exercised 225,473 options at strike prices of $28.67 and $32.71, then immediately sold all resulting shares for $16.2 million at prices between $71.62 and $72.25. The sale represents a significant cash-out by the top executive, reducing his direct holdings to 615,771 shares. While option exercises are routine, the simultaneous open-market sale of the entire exercised amount signals a lack of near-term conviction, especially coming just days after the company reported blowout Q2 earnings and guided for strong refinery utilization. The transaction is not part of a 10b5-1 plan, making it a discretionary move.
At the time of this filing, PBF was trading at $66.94 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $21.46 to $74.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.